human | Q5 |
P27 | country of citizenship | Poland | Q36 |
P184 | doctoral advisor | Anna Jakubowska | Q58323317 |
P734 | family name | Bieniek | Q15948541 |
Bieniek | Q15948541 | ||
Bieniek | Q15948541 | ||
Jaworska | Q47191882 | ||
Jaworska | Q47191882 | ||
Jaworska | Q47191882 | ||
P735 | given name | Agnieszka | Q16161911 |
Agnieszka | Q16161911 | ||
Katarzyna | Q17318005 | ||
Katarzyna | Q17318005 | ||
P1412 | languages spoken, written or signed | Polish | Q809 |
P1559 | name in native language | Katarzyna Jaworska-Bieniek | |
P103 | native language | Polish | Q809 |
P106 | occupation | researcher | Q1650915 |
molecular biologist | Q15839206 | ||
P21 | sex or gender | female | Q6581072 |
Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
Q60684176 | Abstract LB-159: Methylation of BRCA1 gene in blood is not inherited via maternal germ line and may predispose to triple-negative or medullary breast cancer |
Q35618307 | An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers |
Q55340907 | Arsenic (As) and breast cancer risk. |
Q35242849 | Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers |
Q35957703 | Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer |
Q90414420 | Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population |
Q35523236 | Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers |
Q36466697 | BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population |
Q112162492 | CHAPTER 22. Selenium and Cancer |
Q46658012 | Can selenium be a modifier of cancer risk in CHEK2 mutation carriers? |
Q34693954 | Can selenium levels act as a marker of colorectal cancer risk? |
Q34963894 | Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers |
Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
Q45906878 | Copper as diagnostic marker of cancers. |
Q21144874 | DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers |
Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
Q36087170 | Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers |
Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
Q35151684 | Genetic predisposition to in situ and invasive lobular carcinoma of the breast |
Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
Q36086247 | Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus |
Q36014067 | Identification of novel genetic markers of breast cancer survival |
Q37410472 | Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women |
Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
Q46130512 | Iron as diagnostic marker of cancer. |
Q61818385 | Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidence |
Q46130429 | Magnesium as a diagnostic marker of cancer. |
Q47133182 | Meeting abstracts from the Annual Conference on Hereditary Cancers 2015: Szczecin, Poland. 24-25 September, 2015. |
Q50233852 | Meeting abstracts from the Annual Conference on Hereditary Cancers 2016: Szczecin, Poland. 14-15 September 2016. |
Q85921942 | Methylation of the BRCA1 promoter in peripheral blood DNA is associated with triple-negative and medullary breast cancer |
Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
Q46130604 | Microelements as diagnostic markers of pancreatic cancer. |
Q98240553 | Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population |
Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
Q35665705 | Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers |
Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
Q35155449 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia |
Q38359733 | Selenium as a marker of cancer risk and of selection for control examinations in surveillance |
Q46130885 | Selenium as diagnostic marker of cancers. |
Q48273027 | Serum 25(OH)D concentration, common variants of the VDR gene and lung cancer occurrence |
Q37097470 | Serum Concentrations of Selenium and Copper in Patients Diagnosed with Pancreatic Cancer |
Q54487901 | Serum concentrations of Cu, Se, Fe and Zn in patients diagnosed with pancreatic cancer. |
Q33664315 | Serum folate concentration and the incidence of lung cancer |
Q92341152 | Serum selenium level and cancer risk: a nested case-control study |
Q53849040 | The influence of selenium concentration and variations in selenoprotein genes on the CHEK2-dependent cancers. |
Q46660029 | Zinc and breast cancer risk |
Q45946070 | Zinc as diagnostic marker of cancers. |
Q58323317 | Anna Jakubowska | doctoral student | P185 |
Search more.